SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

Home・Lista de Ações・Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi SA

Fechado

SetorSaúde

59.85 0.5

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

59.25

Máximo

Indicadores-chave
By Trading Economics
Rendimento	-33M 9.5M
Vendas	-66M 152M
P/E Médio do Setor	24.576 49.701
EPS	0.185
Margem de lucro	6.216
Funcionários	1,950
EBITDA	-45M 18M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+22.77% upside

Dividendos
By Dow Jones
Próximos Ganhos	23 de jul. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-1.1B 3B
Abertura anterior	59.35
Fecho anterior	59.85

Sentimento de Notícias

By Acuity

50%

148 / 345 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

51.1 / N/A Suporte e Resistência

Laboratorios Farmaceuticos Rovi SA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de mai. de 2026, 22:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Conduent to Sell Public Transit Business to Modaxo for $164 Million

21 de mai. de 2026, 16:49 UTC

Ganhos

Walmart's Fuel Business Benefits from Rising U.S. Gas Prices, Though Volume Per Transaction Falls -- OPIS

21 de mai. de 2026, 16:26 UTC

Grandes Movimentos do Mercado

Spotify Technology Shares Up Amid New AI Tool For Remixing Songs

21 de mai. de 2026, 23:51 UTC

Conversa de Mercado

Nikkei Might Rise on Continued Hopes for Possible U.S.-Iran Deal -- Market Talk

21 de mai. de 2026, 23:37 UTC

Ganhos

Lenovo Group 4Q Oper Profit $886.0M Vs. $331.0M >0992.HK

21 de mai. de 2026, 23:37 UTC

Ganhos

Lenovo Group 4Q Rev $21.60B Vs. $16.98B >0992.HK

21 de mai. de 2026, 23:37 UTC

Ganhos

Lenovo Group 4Q Net $521.0M Vs. Net $90.0M >0992.HK

21 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Gold Edges Lower Amid Mixed Sentiment -- Market Talk

21 de mai. de 2026, 23:30 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

21 de mai. de 2026, 23:30 UTC

Conversa de Mercado

Napier Port Loses Bull Despite Robust 1H Result -- Market Talk

21 de mai. de 2026, 22:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Conduent to Sell Public Transit Business to Modaxo for $164M

21 de mai. de 2026, 21:53 UTC

Ganhos

Marvell Stock Notches Its 15th Record Closing High This Year -- Barrons.com

21 de mai. de 2026, 21:02 UTC

Ganhos

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, Nebius, Bloom Energy, Applied Digital, Intuit, D-Wave, Spotify, and More -- Barrons.com

21 de mai. de 2026, 20:55 UTC

Ganhos

Walmart Sales Rise as It Navigates Higher Fuel Prices -- 2nd Update

21 de mai. de 2026, 20:30 UTC

Ações em Alta

Stocks to Watch Recap: Nvidia, Spotify, Stellantis, Intuit -- WSJ

21 de mai. de 2026, 20:20 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 de mai. de 2026, 20:20 UTC

Conversa de Mercado

Mexico's Revised 1Q GDP Seen Confirming Contraction -- Market Talk

21 de mai. de 2026, 20:20 UTC

Ganhos

Webull 1Q Adj EPS 3c >BULL

21 de mai. de 2026, 20:20 UTC

Ganhos

Webull 1Q Rev $159.9M >BULL

21 de mai. de 2026, 20:18 UTC

Conversa de Mercado

Mexico's Inflation Seen Easing in Early May -- Market Talk

21 de mai. de 2026, 20:18 UTC

Ganhos

Webull 1Q Loss/Shr 4c

21 de mai. de 2026, 19:43 UTC

Conversa de Mercado

Oil Futures Lose Ground on Hopes for U.S.-Iran Deal -- Market Talk

21 de mai. de 2026, 19:33 UTC

Conversa de Mercado

U.S. Natural Gas Futures Edge Up in Steady Trading -- Market Talk

21 de mai. de 2026, 18:58 UTC

Ganhos

Nvidia Is Now the Megacap Cash Machine, and Big Tech Is Footing the Bill -- Barrons.com

21 de mai. de 2026, 18:15 UTC

Conversa de Mercado

Gold Higher For Second Consecutive Day -- Market Talk

21 de mai. de 2026, 17:40 UTC

Conversa de Mercado

Prolonged War Putting Energy Normalcy Further Away -- Market Talk

21 de mai. de 2026, 17:04 UTC

Conversa de Mercado

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21 de mai. de 2026, 17:01 UTC

Ganhos

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, GlobalFoundries, Nebius, Applied Digital, Intuit, Spotify, and More -- Barrons.com

21 de mai. de 2026, 16:20 UTC

Conversa de Mercado

Ganhos

Stellantis Targets Distant but Constructive -- Market Talk

21 de mai. de 2026, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

Comparação entre Pares

Variação de preço

Laboratorios Farmaceuticos Rovi SA Previsão

Preço-alvo

By TipRanks

22.77% parte superior

Previsão para 12 meses

Média 73.6 EUR 22.77%

Máximo 83 EUR

Mínimo 64.2 EUR

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Laboratorios Farmaceuticos Rovi SA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

Comprar

Manter

Vender

Com base em 2 analistas que deram avaliações de ações para Laboratorios Farmaceuticos Rovi SA - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

51.1 / N/ASuporte e Resistência

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

Sentimento

By Acuity

148 / 345 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.